After soaring following the election, Tesla (NASDAQ: TSLA) stock ran into a wall in February as a number of news items, macro challenges, and CEO Elon Musk's involvement in the Department of ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

After soaring after the election, the Trump-fueled momentum fell apart last month. A number of headwinds, including on a macro level and Musk's own political activity, weighed on the stock. In ...

Shares of online learning platform company Nerdy (NYSE: NRDY) fell hard today after the company reported its fourth-quarter results yesterday. While sales and earnings beat Wall Street's consensus ...

The Northwest Territories government is working with territorial school authorities to understand how a federal decision to narrow Jordan's Principle eligibility criteria will affect their ability to ...

Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...

An icon in the shape of a lightning bolt. Impact Link Tesla sales in Europe plunged in January, falling 45% compared with the same month last year, while overall sales of electric vehicles ...

Hims and Hers plans to stop selling compounded weight loss drugs after an FDA update. Hims and Hers' stock fell over 19% in after-hours trading on Monday. The FDA removed semaglutide injections ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

Michael Hill recently reported a minor decline in revenue across the first half of the financial year, spurred by sales struggles in New Zealand. Conversely, sales improved in the Australian and ...